Logo

People in the News: Exosome Diagnostics Names O'Neill as CMO

Jun 05, 2014
Premium

Exosome Diagnostics said this week that it has appointed Vincent O'Neill as chief medical officer.

O'Neill most recently served as global head of personalized medicine and companion diagnostics at Sanofi. Prior to this, he managed the clinical development programs of several oncology therapeutic candidates at Genetech and GlaxoSmithKline. He holds a BS in pathology and MBChB and MD from the University of Glasgow.

Filed under

PCR
Diagnostics
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.